# myEyeris

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/myeyeris

- Industry: Healthcare Specialists
- Headquarters: Nashville, US
- Website: www.myeyeris.com
- Total disclosed funding: $0.1M
- Latest round: Seed (May 30, 2018)
- Investors on record: 1

## About

myEyeris, Inc. is a company focused on developing innovative contact lenses that prioritize comfort and eye health for users seeking alternatives to traditional eyewear.Founded in 2018, myEyeris, Inc. specializes in contact lens technology, headquartered in Nashville, US. Modar Alaoui, the founder, has a history in eye care innovation. The company raised USD 1.85 mn in funding on September 5, 2019, totaling USD 1.85 mn raised across three deals.Eyeris specializes in the development and sale of high-quality contact lenses designed to prioritize comfort and eye health. Their core product offerings include daily disposable lenses made from a proprietary material called Hioxifilcon, which boasts the lowest stiffness rating in the market, ensuring a softer and more comfortable fit. Eyeris lenses feature a unique blend of time-released emollients, higher water content (59% H2O), and advanced cross-linking designs that enhance breathability and moisture retention, catering to users needing long-wearing comfort. These products primarily serve a diverse clientele, including individuals seeking alternatives to traditional eyeglasses, as well as first-time contact lens wearers who prioritize comfort. Eyeris products are marketed across various geographical regions, focusing on North America and expanding into parts of Europe and Asia, aiming to reach a broad audience looking for innovative eye care solutions.Eyeris generates revenue through direct-to-consumer sales and partnerships with eye care professionals and clinics. Their business model typically involves providing eye care providers with trial lenses, which facilitate the fitting process for patients. Once fitted, customers can order their preferred Eyeris lenses through these healthcare providers, establishing a recurring revenue stream as patients return for regular lens supplies. The pricing structure is designed to be competitive, allowing for a range of corrective strengths to accommodate various vision needs. Eyeris emphasizes accessibility and affordability in its offerings, ensuring that patients can enjoy a comfortable alternative to conventional lenses without incurring excessive costs. The company’s commitment to eye health and environmental sustainability further enhances its appeal in the marketplace.In the coming years, myEyeris, Inc. plans to introduce new products that incorporate advanced materials for enhanced user comfort, with specific launches expected by mid-2024. The company aims to expand its market presence in Europe and Asia, targeting regions like Germany and Japan by the end of 2025. Funding from the recent raise of USD 1.85 mn will support these growth initiatives, enabling the development of new products and marketing strategies to penetrate these new markets.

## Funding rounds

- Seed, May 30, 2018, $0.1M — Jumpstart Health Investors

## Investors

- Jumpstart Health Investors (https://capitalatlas.ai/funds/jumpstart-health-investors) — Seed